SCHEMBL21201359

SCHEMBL21201359

Cn1cnnc1C(F)(F)C(C)(F)c1cccc(NC(=O)c2nc3c(C(F)(F)F)cccc3[nH]2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CBLB Q13191 17/20 1.00
▸ AKR1C3 P42330 1/20 0.41
▸ CHUK O15111 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21201358 1.00 CBLB (1.00) CBLBAKR1C3CHUK
SCHEMBL21212545 0.82 CBLB (0.71) CBLB
SCHEMBL21200198 0.79 CBLB (0.66) CBLBAKR1C3
SCHEMBL21212081 0.77 CBLB (1.00) CBLB
SCHEMBL29867489 0.77 CBLB (1.00) CBLB
SCHEMBL21211830 0.77 CBLB (1.00) CBLB
SCHEMBL22944961 0.75 CBLB (0.62) CBLBAKR1C3
SCHEMBL29640139 0.75 CBLB (0.62) CBLBAKR1C3
SCHEMBL21200238 0.74 CBLB (0.66) CBLB
SCHEMBL21212207 0.73 CBLB (1.00) CBLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3743063-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF Nurix Therapeutics, Inc. (US) 2020-12-02 — — EP disclosed
WO-2019148005-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF NURIX THERAPEUTICS, INC. (US) 2019-08-01 — — WO disclosed
Send feedback